Home › Insider buying › OKUR

OnKure Therapeutics, Inc. (OKUR): insider trading, Congress trades & who owns it

By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Insider signal
33/100
Insider selling · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$6K
2 sellers · 12 months
Funds holding
75
13F · Q2 2026
Congress trades
None
none in 2 years

Over the past year there were no insider purchases at OnKure Therapeutics, Inc.. Two insiders sold roughly $5,632 instead.

Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.

On the institutional side, 75 funds reported holding OKUR at the end of Q2 2026, and more funds bought than sold. Quarter by quarter: 6 quarters in a row of net selling by insiders. Insiders bought in 1 of the last 7 full quarters.

Want the full picture on OKUR? Financials, dilution history, a written bull & bear case, top holders and alerts.
See the full OKUR report — free account

Latest insider trades in OKUR

FiledInsiderRoleTypeSharesPriceValueSource
Sep 23, 2026Saccomano Nicholas ACEOSell87$2.97$258SEC
Sep 23, 2026Leverone Jason A.CFOSell302$2.97$897SEC
Jun 24, 2026Saccomano Nicholas ACEOSell86$4.40$378SEC
Jun 24, 2026Leverone Jason A.CFOSell303$4.40$1KSEC
Mar 24, 2026Saccomano Nicholas ACEOSell86$4.16$358SEC
Mar 24, 2026Leverone Jason A.CFOSell301$4.16$1KSEC
Dec 23, 2025Saccomano Nicholas ACEOSell87$2.97$258SEC
Dec 23, 2025Leverone Jason A.CFOSell302$2.97$897SEC
Sep 24, 2025Saccomano Nicholas ACEOSell88$2.62$231SEC
Sep 24, 2025Leverone Jason A.CFOSell303$2.62$794SEC
Jun 25, 2025Saccomano Nicholas ACEOSell88$2.38$209SEC
Jun 25, 2025Leverone Jason A.CFOSell303$2.38$721SEC
May 19, 2025Cormorant Private Healthcare Fund III LPOtherSell1,813,439$1.85$3.4MSEC
May 19, 2025ACORN CAPITAL ADVISORS GP, LLC10% OwnerBuy1,129,730$1.85$2.1MSEC
May 19, 2025ACORN CAPITAL ADVISORS GP, LLC10% OwnerBuy270,270$1.85$500KSEC

Questions about OKUR

Are insiders buying or selling OKUR stock?

In the last 12 months OnKure Therapeutics, Inc. insiders made open-market purchases worth about $0 and sales worth about $5,632. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

When was the last insider trade in OKUR?

The most recent open-market insider trade in OKUR was filed on 2026-09-23.

How many institutions own OKUR?

75 investment managers reported holding OKUR in SEC Form 13F filings for Q2 2026.

Has any member of Congress traded OKUR?

No congressional trades in OKUR were reported in the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

GGRBBDCRBGBPREREFOPTUPRTAN.A.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).